UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055334
Receipt number R000063214
Scientific Title Hypothesis generating study to assess 3-month personal health record (Fitbit) retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement
Date of disclosure of the study information 2024/08/28
Last modified on 2025/02/04 11:59:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study to assess 3-month Fitbit retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement

Acronym

Study to assess 3-month Fitbit retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement

Scientific Title

Hypothesis generating study to assess 3-month personal health record (Fitbit) retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement

Scientific Title:Acronym

Hypothesis generating study to assess 3-month personal health record (Fitbit) retention and exercise tolerance in outpatients undergoing outpatient cardiac rehabilitation after transcatheter aortic valve replacement

Region

Japan


Condition

Condition

severe aortic valve stenosis

Classification by specialty

Cardiology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A single-center, single-arm, hypothesis-generating intervention study was designed to determine the primary outcome of 3-month retention of a wristwatch personal health record (PHR) (hereafter referred to as Fitbit) in patients undergoing transcatheter aortic valve implantation (TAVI). A single-center, single-arm, hypothesis-generating intervention study was designed with a primary outcome of retention of wristwatch personal health record (PHR) (henceforth Fitbit) use. Secondary outcomes will be the representative values of heart rate and step rate measured by Fitbit, as well as the 6-minute walk test, which will be evaluated over time. This study focuses on confirming the acceptability of Fitbit in the TAVI patient population for the very elderly and frail.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Percentage of Fitbit wearers who continue to wear the Fitbit at 3 months after TAVI

Key secondary outcomes

1) The following items at the beginning of the intervention and 3 months later
6-minute walking distance over time
2) Representative values (mean, median, mode, maximum, and minimum) of number of steps and heart rate measured by Fitbit


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Patients indicated for TAVI will be fitted with a wearable device (Fitbit) at the start of their first post-TAVI exercise rehearsal.
The primary outcome will be the 3-month retention rate of wearing the Fitbit, with Day 0 as the initial rehabilitation period.
The target number of patients is 30.
The number of interventions will be the 6-minute walk test at the beginning of the initial exercise rehearsal and at the end of the 3-month exercise rehearsal.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who meet all of the following criteria are eligible
1) Patients who have undergone TAVI in severe aortic stenosis
2) Patients aged 60 years or older at the time of consent (regardless of gender)
3) Research subjects who have given a full explanation of their participation in this study and have given their free written consent.
4) Patients scheduled for outpatient cardiac rehabilitation

Key exclusion criteria

Patients who violate any of the following conditions will not be included in this study
1) Patients who do not have a reliable Internet connection at home, do not have a smartphone, or are otherwise unable to establish a Fitbit use environment.
2) Patients for whom exercise therapy is contraindicated
3) Patients who have difficulty performing the exercise tolerance test due to other diseases or pain
4) Patients who have difficulty operating the Fitbit due to visual or hearing impairment
5) Patients who have experienced hypotension, fatal arrhythmia, or other adverse events during cardiac rehabilitation, exercise stress tests, or exercise therapy.
5) Patients who have experienced hypotension, fatal arrhythmia or other adverse events during cardiac rehabilitation, exercise testing or exercise therapy
6) Patients scheduled to undergo inpatient cardiac rehabilitation for more than 4 weeks
7) Patients who have participated in other clinical trials or clinical studies involving interventions within the past 12 weeks of obtaining consent
8) Patients who the investigator determines to be incapable of correctly understanding the significance of the research and complying with the compliance requirements due to dementia, mental illness, etc.
9) Other patients who are judged by the principal investigator to be inappropriate as research subjects

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Shigeru
Middle name
Last name Saito

Organization

Shonan Kamakura General Hospital

Division name

Cardiac Center

Zip code

247-8533

Address

1370-1 Okamoto,Kamakura-City

TEL

0467-46-1717

Email

transradial@kamakuraheart.org


Public contact

Name of contact person

1st name Futoshi
Middle name
Last name Yamanaka

Organization

Shonan Kamakura General Hospital

Division name

Cardiac Center

Zip code

247-8533

Address

1370-1 Okamoto,Kamakura-City

TEL

0467-46-1717

Homepage URL


Email

futoshi.yamanaka@gmail.com


Sponsor or person

Institute

Shonan Kamakura General Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Tokushukai Group Ethics Commitee

Address

15F, Tokyo-Do Chiyoda Bldg. 1-3-1 Kudan-Minami, Chiyoda-ku, Tokyo, Japan

Tel

0332634801

Email

crb_itoku@shonankamakura.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 08 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 08 Month 19 Day

Date of IRB

2024 Year 08 Month 27 Day

Anticipated trial start date

2025 Year 02 Month 01 Day

Last follow-up date

2025 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2026 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2024 Year 08 Month 26 Day

Last modified on

2025 Year 02 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063214